FIELD: medicine.
SUBSTANCE: invention refers to a method of producing indolo[2,3]pyrrolo[3,4-C]carbazole-5,7-dione N-glycosides of general formula (Ia-d), where Gly means (a) L-arabinopyranosyl-, (b) D-galactopyranosyl-, (c) D-ribopyranosyl-, (d) D-xylopyranosyl-. The offered method involves 1) reaction of appropriate acetyl glycosylinole and oxalyl chloride in methylene chloride with producing appropriate acetyl glycoside indole-3-ylglyoxylyl chloride, 2) addition of 1-formylindole-3-ylacetic acid and triethylamine in a dioxane medium with producing appropriate 3-(indole-3-yl)-4 (acetylglycosylindole-3-yl)furan-2,5-dione derivative which are isolated by adding water in a reaction mass to isolate a prepared product as a precipitate not requiring preliminary purification for the further stages, 3) photochemical oxidation of the product prepared at the previous stage in the presence of iodine in benzene to appropriate furanocarbazole derivative, 4) following processing of furanocarbazole derivative by an aqueous solution of ammonia in N,N-dimethylformamide at high temperature and pressure. Indolo[2,3]pyrrolo[3,4-C]carbazole-5,7-dione glycosides prepared thereby exhibit evident cytotoxic and anticancer activity with respect to cervical carcinoma CC-5, lymphocytic leukemia L-5178y and ascitic Ehrlich's tumours.
EFFECT: higher cytotoxic and anticancer activity of the compositions.
3 cl, 4 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
N-GLYCOSIDES OF INDOLO[2,3-a]PYRROLO[3,4-c]CARBAZOLES HAVING ANTITUMOUR ACTIVITY | 2014 |
|
RU2548045C1 |
DERIVATIVE OF THE CLASS OF N-GLYCOSIDES INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOLE-5,7-DIONE - N-{12-(β-D-XYLOPYRANOSYL)-5,7-DIOXO-INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOL-6-YL} PYRIDINE-2-CARBOXAMIDE, WHICH HAS CYTOTOXIC AND ANTITUMOR ACTIVITY | 2017 |
|
RU2667906C1 |
DERIVATIVES OF GLYCOSIDES OF INDOLO[2,3-A]-PYRROLO[3,4-C]CARBAZOL-5,7-DIONES ELICITING CYTOTOXIC AND ANTITUMOR ACTIVITY | 2003 |
|
RU2255089C1 |
INDOLOCARBAZOLE DERIVATIVE BLOCKING TUMOUR VASCULOGENIC MIMICRY | 2014 |
|
RU2557554C1 |
ANTITUMOUR AGENT | 2014 |
|
RU2572691C1 |
INHIBITOR OF GUANYLATE CYCLASE SOLUBLE FORM | 2001 |
|
RU2196175C2 |
AGENT STIMULATING HUMAN LEUKAEMIA CELL APOPTOSIS (VERSIONS) | 2007 |
|
RU2372919C2 |
METHOD FOR PRODUCING AMINO ACID ANALOGUES OF THE ANTITUMOUR ANTIBIOTIC REBECCAMYCIN | 2020 |
|
RU2755572C1 |
METHOD OF PRODUCING HETEROCYCLIC ACID OR THEIR SALTS | 0 |
|
SU1545940A3 |
2-R-6-R-5-ARYL-PYRROLE[3,4-c]CARBAZOLE-1,3(2H,6H)-DIONE SYNTHESIS METHOD | 2009 |
|
RU2404983C1 |
Authors
Dates
2011-08-27—Published
2009-12-10—Filed